Antithymocyte immunoglobulin (rabbit) Completed Phase 4 Trials for Acute Graft-Versus-Host Disease (GVHD) Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT02677181Efficacy and Safety Study of ATG for Prophylaxis of aGVHD in Matched Sibling Donor PBSCT